Verification of Risk Factors of Thrombohemorrhagic Complications in Recipients After Related Liver Transplantation

ConditionsLiver Cirrhosis Liver Transplant; Complications

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18-70

SponsorRepublican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

About this trial

The aim of the study is to improve the results of related transplantation of the right liver lobe by verifying the general predictors of the development of hemostatic system disorders and optimizing a comprehensive program for thrombohemorrhagic complications preventing.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age over 18 years and up to 70 years;

Signed informed consent for inclusion to the study;

End stage liver cirrhosis.

Disqualifiers

Pregnancy;

Extrahepatic factors influencing systemic hemostasis;

Concomitant hematological diseases affecting the hemostatic system;

Severe concomitant disorders.

Trial population

Patients with end stage liver cirrhosis who underwent living related liver transplantation.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

Liver transplantation
Procedure/Surgery
Related transplantation of the right lobe of the liver

Treatment groups

30 Participants

are divided into 1 treatment group

Group A: liver transplant group1 intervention

Trial outcomes

Primary outcomes

Thrombosis of vascular anastomosis

Thrombosis of arterial or venous anastomosis after intervention

Time frame

1 month

Secondary outcomes

Hemorrhagic complications

Any hemorrhagic complications after intervention

Time frame

1 month

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Republican Specialized Scientific and Practical Medical Center of Surgery Named After V. Vakhidov

Lead sponsor

Source ClinicalTrials.gov

Apply now